Kevin Punie, Medical Oncologist at GZA Hospitals Sint-Augustinus, Wilrijk, Antwerp, Belgium shared a post on X:
“Carmen Criscit provides excellent guidance in decision making between olaparib and abemaciclib in patients with early-stage high-risk HR+/HER2- breast cancer with overlapping indications.”
Source: Kevin Punie/X
